Literature DB >> 32243968

Protein-based nanoparticles for drug delivery purposes.

Ana L Martínez-López1, Cristina Pangua1, Cristian Reboredo1, Raquel Campión1, Jorge Morales-Gracia1, Juan M Irache2.   

Abstract

Proteins represent a group of biopolymers with interesting properties to be employed as raw materials in the preparation of nanoparticles for drug delivery purposes. Due to the inherent properties of proteins (i.e., biodegradability, amphiphilic properties, etc.) the resulting nanoparticles can be considered as versatility platforms for a variety of applications. Moreover, some proteins possess a GRAS (Generally Recognized as Safe) status or are considered as excipients by different Regulatory Agencies. As result of this, the resulting nanoparticles and potential translation to clinic would be facilitated, compared to other materials (i.e., polymers). This review is focused on the main proteins employed in the preparation of nanoparticles as well as the procedures permitting their transformation into nanoparticles able of accommodating a high variety of bioactive compounds and drugs. Moreover, the review also provides examples of application of nanoparticles prepared from albumins, globulins, prolamins or macromolecules derived from proteins.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albumin; Casein; Gelatin; Lactoglobulin; Nanoparticles; Protein; Zein

Mesh:

Substances:

Year:  2020        PMID: 32243968     DOI: 10.1016/j.ijpharm.2020.119289

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Multiplexed Analysis of the Cellular Uptake of Polymeric Nanocarriers.

Authors:  Dheeraj K Agrohia; Peidong Wu; Uyen Huynh; S Thayumanavan; Richard W Vachet
Journal:  Anal Chem       Date:  2022-05-25       Impact factor: 8.008

2.  Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans.

Authors:  Ana L Martínez-López; Carlos J González-Navarro; José L Vizmanos; Juan M Irache
Journal:  Drug Deliv Transl Res       Date:  2021-01-29       Impact factor: 4.617

3.  In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions.

Authors:  Ana L Martínez-López; Carlos J González-Navarro; Paula Aranaz; José L Vizmanos; Juan M Irache
Journal:  Acta Pharm Sin B       Date:  2021-03-01       Impact factor: 11.413

4.  Investigating the Antimicrobial Activity of Vancomycin-Loaded Soy Protein Nanoparticles.

Authors:  Hadi Zare-Zardini; Hossein Soltaninejad; Adel Ghorani-Azam; Mohammad Javad Forouzani-Moghaddam; Sima Mozafri; Zohreh Akhoundi-Meybodi; Farzad Ferdosian; Fatemeh Jabinian
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-06-29

5.  Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - III - Cow's milk allergens and mechanisms triggering immune activation.

Authors:  Sebastian A Jensen; Alessandro Fiocchi; Ton Baars; Galateja Jordakieva; Anna Nowak-Wegrzyn; Isabella Pali-Schöll; Stefano Passanisi; Christina L Pranger; Franziska Roth-Walter; Kristiina Takkinen; Amal H Assa'ad; Carina Venter; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2022-09-15       Impact factor: 5.516

Review 6.  Application Perspectives of Nanomedicine in Cancer Treatment.

Authors:  Shanshan Hou; Muhammad Hasnat; Ziwei Chen; Yinong Liu; Mirza Muhammad Faran Ashraf Baig; Fuhe Liu; Zelong Chen
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

7.  Purification and erythrocyte-membrane perturbing activity of a ketose-specific lectin from Moringa oleifera seeds.

Authors:  Tolulope Nubi; Taiwo Scholes Adewole; Titilayo Oluwaseun Agunbiade; Olukemi Adetutu Osukoya; Adenike Kuku
Journal:  Biotechnol Rep (Amst)       Date:  2021-06-19

8.  Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.

Authors:  Ying Xiao; Yuewen Gao; Fajuan Li; Zhihe Deng
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.